A high throughput glucocerebrosidase assay using the natural substrate glucosylceramide

Analytical and Bioanalytical Chemistry

Volumn 402, Issue 2, 2012, Pages 731-739

  Motabar, Omid ^a   Goldin, Ehud ^a   Leister, William ^a   Liu, Ke ^a   Southall, Noel ^a   Huang, Wenwei ^a   Marugan, Juan J ^a   Sidransky, Ellen ^a   Zheng, Wei ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Enzyme substrate; Gaucher disease; Glucocerebrosidase; Inhibitor; Natural substrate

Indexed keywords

ENZYME SUBSTRATES; GAUCHER DISEASE; GLUCOCEREBROSIDASE; INHIBITOR; NATURAL SUBSTRATES;

AMIDES; ASSAYS; DISEASE CONTROL; DISEASES; ENZYMES; GLUCOSE; LEAD COMPOUNDS; THROUGHPUT;

SUBSTRATES;

GLUCOSYLCERAMIDASE; GLUCOSYLCERAMIDE;

ARTICLE; CHEMISTRY; ENZYME ASSAY; HIGH THROUGHPUT SCREENING; KINETICS; METABOLISM; METHODOLOGY;

ENZYME ASSAYS; GLUCOSYLCERAMIDASE; GLUCOSYLCERAMIDES; HIGH-THROUGHPUT SCREENING ASSAYS; KINETICS;

EID: 84856220345     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-011-5496-z     Document Type: Article

References (24)

1. GA Grabowski 1993 Gaucher disease. Enzymology, genetics, and treatment Adv Hum Genet 21 377 441 10.1007/978-1-4615-3010-7-5 1:CAS:528: DyaK3sXmtVSltbk%3D
2. E Sidransky ME LaMarca EI Ginns 2007 Therapy for Gaucher disease: don't stop thinking about tomorrow Mol Genet Metab 90 2 122 125 10.1016/j.ymgme.2006. 09.007 1:CAS:528:DC%2BD2sXnsl2ksA%3D%3D (Pubitemid 46108615)
3. BE Smid JM Aerts RG Boot GE Linthorst CE Hollak 2010 Pharmacological small molecules for the treatment of lysosomal storage disorders Expert Opin Investig Drugs 19 11 1367 1379 10.1517/13543784.2010.524205 10.1517/13543784. 2010.524205 1:CAS:528:DC%2BC3cXhtlWmurfL
4. R Khanna ER Benjamin L Pellegrino A Schilling BA Rigat R Soska H Nafar BE Ranes J Feng Y Lun AC Powe DJ Palling BA Wustman R Schiffmann DJ Mahuran DJ Lockhart KJ Valenzano 2010 The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase Febs J 277 7 1618 1638 10.1111/j.1742-4658.2010.07588.x 1:CAS:528:DC%2BC3cXktFOntL8%3D
5. M Beck 2010 Therapy for lysosomal storage disorders IUBMB Life 62 1 33 40 1:CAS:528:DC%2BC3cXktlemuw%3D%3D
6. G Parenti 2009 Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics EMBO Mol Med 1 5 268 279 10.1002/emmm.200900036 1:CAS:528:DC%2BD1MXht1CjurrF
7. G Parenti G Andria 2011 Pompe disease: from new views on pathophysiology to innovative therapeutic strategies Curr Pharm Biotechnol 12 6 902 915 10.2174/138920111795542606 1:CAS:528:DC%2BC3MXmvFehsbg%3D
8. P Rozenfeld PM Neumann 2011 Treatment of fabry disease: current and emerging strategies Curr Pharm Biotechnol 12 6 916 922 10.2174/ 138920111795542705 1:CAS:528:DC%2BC3MXmvFehsbk%3D
9. GM Pastores P Giraldo P Cherin A Mehta 2009 Goal-oriented therapy with miglustat in Gaucher disease Curr Med Res Opin 25 1 23 37 10.1185/ 03007990802576518 1:CAS:528:DC%2BD1MXkvFCktrw%3D
10. M Owada T Sakiyama T Kitagawa 1977 Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver Pediatr Res 11 5 641 646 10.1203/00006450-197705000-00004 1:CAS:528:DyaE2sXkt1SjsL8%3D (Pubitemid 8095459)
11. DM Broadhead J Butterworth 1977 The diagnosis of Gaucher's disease in liver using 4-methylumbelliferyl-beta-D-glucopyranoside Clin Chim Acta 75 1 155 161 10.1016/0009-8981(77)90512-5 1:CAS:528:DyaE2sXhtlGrsrY%3D (Pubitemid 8030870)
12. DJ Urban W Zheng O Goker-Alpan A Jadhav ME Lamarca J Inglese E Sidransky CP Austin 2008 Optimization and validation of two miniaturized glucocerebrosidase enzyme assays for high throughput screening Comb Chem High Throughput Screen 11 10 817 824 10.2174/138620708786734244 1:CAS:528: DC%2BD1cXhsVSitrvE
13. WS Hays DE Wheeler B Eghtesad RH Glew DE Johnston 1998 Expression of cytosolic beta-glucosidase in guinea pig liver cells Hepatology 28 1 156 163 10.1002/hep.510280121 1:CAS:528:DyaK1cXks1aqsbo%3D (Pubitemid 28299997)
14. BC Zhu G Henderson RA Laine 2005 Screening method for inhibitors against formosan subterranean termite beta-glucosidases in vivo J Econ Entomol 98 1 41 46 10.1603/0022-0493-98.1.41 1:CAS:528:DC%2BD2MXhslyhsbw%3D (Pubitemid 40328462)
15. HH van Es M Veldwijk M Havenga D Valerio 1997 A flow cytometric assay for lysosomal glucocerebrosidase Anal Biochem 247 2 268 271 10.1006/abio.1997.2090 (Pubitemid 27200160)
16. Y Ben-Yoseph HL Nadler 1978 Pitfalls in the use of artificial substrates for the diagnosis of Gaucher's disease J Clin Pathol 31 11 1091 1093 10.1136/jcp.31.11.1091 1:STN:280:DyaE1M7gvF2msQ%3D%3D (Pubitemid 9068639)
17. Wenger D, Olsen GC (1981) Heterogeneity in Gaucher disease. In: Callahan JW, Lowden JA (eds) Lysosomes and lysosomal storage diseases. Raven, New York, pp 157-171
18. FY Choy RG Davidson 1980 Gaucher disease. III. Substrate specificity of glucocerebrosidase and the use of nonlabeled natural substrates for the investigation of patients Am J Hum Genet 32 5 670 680 1:CAS:528: DyaL3cXmtFOjsbo%3D (Pubitemid 10061687)
19. Y Hayashi K Zama E Abe N Okino T Inoue K Ohno M Ito 2008 A sensitive and reproducible fluorescent-based HPLC assay to measure the activity of acid as well as neutral beta-glucocerebrosidases Anal Biochem 383 1 122 129 10.1016/j.ab.2008.07.024 1:CAS:528:DC%2BD1cXht1SiurfM
20. P Mazura R Fohlerova B Brzobohaty NS Kiran L Janda 2006 A new, sensitive method for enzyme kinetic studies of scarce glucosides J Biochem Biophys Methods 68 1 55 63 10.1016/j.jbbm.2006.03.018 1:CAS:528:DC%2BD28XlsFKku7g%3D (Pubitemid 43870310)
21. Y Zhu JL Jiang NK Gumlaw J Zhang SD Bercury RJ Ziegler K Lee M Kudo WM Canfield T Edmunds C Jiang RJ Mattaliano SH Cheng 2009 Glycoengineered acid alpha-glucosidase with improved efficacy at correcting the metabolic aberrations and motor function deficits in a mouse model of Pompe disease Mol Ther 17 6 954 963 10.1038/mt.2009.37 1:CAS:528:DC%2BD1MXivVKmsrc%3D
22. JJ Marugan W Zheng O Motabar N Southall E Goldin E Sidransky RA Aungst K Liu SK Sadhukhan CP Austin 2010 Evaluation of 2-thioxo-2,3,5,6,7,8- hexahydropyrimido[4,5-d]pyrimidin-4(1H)-one analogues as GAA activators Eur J Med Chem 45 5 1880 1897 10.1016/j.ejmech.2010.01.027 1:CAS:528: DC%2BC3cXjs12qsL4%3D
23. O Motabar K Liu N Southall JJ Marugan E Goldin E Sidransky W Zheng 2010 High throughput screening for inhibitors of alpha-galactosidase Curr Chem Genomics 4 67 73 10.2174/1875397301004010067 1:CAS:528:DC%2BC3MXpt1aqsg%3D%3D
24. SP Peters P Coyle RH Glew 1976 Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate Arch Biochem Biophys 175 2 569 582 10.1016/0003-9861(76)90547-6 1:CAS:528:DyaE28XkslCjsrs%3D